IRIS Accounts Production v24.3.0.553 10390547 Board of Directors 1.10.23 30.9.24 30.9.24 0 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh103905472023-09-30103905472024-09-30103905472023-10-012024-09-30103905472022-09-30103905472022-10-012023-09-30103905472023-09-3010390547ns15:EnglandWales2023-10-012024-09-3010390547ns14:PoundSterling2023-10-012024-09-3010390547ns10:Director12023-10-012024-09-3010390547ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3010390547ns10:SmallEntities2023-10-012024-09-3010390547ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-3010390547ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3010390547ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3010390547ns10:FullAccounts2023-10-012024-09-3010390547ns10:OrdinaryShareClass12023-10-012024-09-3010390547ns10:Director22023-10-012024-09-3010390547ns10:CompanySecretary12023-10-012024-09-3010390547ns10:RegisteredOffice2023-10-012024-09-3010390547ns5:CurrentFinancialInstruments2024-09-3010390547ns5:CurrentFinancialInstruments2023-09-3010390547ns5:ShareCapital2024-09-3010390547ns5:ShareCapital2023-09-3010390547ns5:RetainedEarningsAccumulatedLosses2024-09-3010390547ns5:RetainedEarningsAccumulatedLosses2023-09-3010390547ns5:PlantMachinery2023-09-3010390547ns5:PlantMachinery2023-10-012024-09-3010390547ns5:PlantMachinery2024-09-3010390547ns5:PlantMachinery2023-09-3010390547ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3010390547ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-3010390547ns5:DeferredTaxation2023-09-3010390547ns5:DeferredTaxation2024-09-3010390547ns10:OrdinaryShareClass12024-09-3010390547ns5:RetainedEarningsAccumulatedLosses2023-09-3010390547ns5:RetainedEarningsAccumulatedLosses2023-10-012024-09-30
REGISTERED NUMBER: 10390547 (England and Wales)












UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2024

FOR

KURTIS MEDICAL LTD.

KURTIS MEDICAL LTD. (REGISTERED NUMBER: 10390547)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


KURTIS MEDICAL LTD.

COMPANY INFORMATION
FOR THE YEAR ENDED 30 SEPTEMBER 2024







DIRECTORS: R E Kurtis
Mrs A J Kurtis





SECRETARY: Mrs A J Kurtis





REGISTERED OFFICE: Lothing House
7 Quay View Business Park
Barnards Way
Lowestoft
Suffolk
NR32 2HD





REGISTERED NUMBER: 10390547 (England and Wales)





ACCOUNTANTS: Juler Tooke
Lothing House
Quay View Business Park
Barnards Way
Lowestoft
Suffolk
NR32 2HD

KURTIS MEDICAL LTD. (REGISTERED NUMBER: 10390547)

BALANCE SHEET
30 SEPTEMBER 2024

30.9.24 30.9.23
Notes £    £   
FIXED ASSETS
Tangible assets 4 - 165

CURRENT ASSETS
Debtors 5 18,916 4,000
Cash at bank 14,455 5,722
33,371 9,722
CREDITORS
Amounts falling due within one year 6 (8,934 ) (8,550 )
NET CURRENT ASSETS 24,437 1,172
TOTAL ASSETS LESS CURRENT
LIABILITIES

24,437

1,337

PROVISIONS FOR LIABILITIES 7 - (31 )
NET ASSETS 24,437 1,306

CAPITAL AND RESERVES
Called up share capital 8 100 100
Retained earnings 9 24,337 1,206
SHAREHOLDERS' FUNDS 24,437 1,306

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 24 October 2024 and were signed on its behalf by:



R E Kurtis - Director


KURTIS MEDICAL LTD. (REGISTERED NUMBER: 10390547)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

1. STATUTORY INFORMATION

Kurtis Medical Ltd. is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - 2 ).

KURTIS MEDICAL LTD. (REGISTERED NUMBER: 10390547)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 October 2023 404
Disposals (404 )
At 30 September 2024 -
DEPRECIATION
At 1 October 2023 239
Charge for year 115
Eliminated on disposal (354 )
At 30 September 2024 -
NET BOOK VALUE
At 30 September 2024 -
At 30 September 2023 165

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Trade debtors - 4,000
Other debtors 18,916 -
18,916 4,000

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Trade creditors 427 361
Taxation and social security 8,507 7,674
Other creditors - 515
8,934 8,550

7. PROVISIONS FOR LIABILITIES
30.9.24 30.9.23
£    £   
Deferred tax - 31

Deferred
tax
£   
Balance at 1 October 2023 31
Balance at 30 September 2024 31

KURTIS MEDICAL LTD. (REGISTERED NUMBER: 10390547)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.9.24 30.9.23
value: £    £   
100 Ordinary £1 100 100

9. RESERVES
Retained
earnings
£   

At 1 October 2023 1,206
Profit for the year 36,131
Dividends (13,000 )
At 30 September 2024 24,337

10. ULTIMATE CONTROLLING PARTY

The company was under the control of Mr & Mrs R Kurtis as holders of the share capital throughout the current
and previous year.
The company operates a Loan account with the Directors and the balance as at 30 September 2024 was £(18,916) (30 September 2023 was £515).The overdrawn balance has been repaid since the balance sheet date.